Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Design Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 60 | 63 | +3 |
| Shares | 36.2M | 38.0M | +1.82M (+5.0%) |
| Value | $773.1M | $613.7M | −$159.4M (−20.6%) |
New holders (6)
Institutions that held Design Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 226,511 | $3.66M | 0.00% |
| Amalgamated Bank | 3,871 | $63.0K | 0.00% |
| Amalgamated Financial Corp. | 3,871 | $63.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1,448 | $23.0K | 0.00% |
| Prospera Financial Services Inc | 1,404 | $23.0K | 0.00% |
| Assetmark, Inc | 263 | $4.00K | 0.00% |
Sold out (3)
Institutions that held Design Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 280,991 | $6.02M |
| Invesco Ltd. | 9,622 | $206.0K |
| SG Americas Securities, LLC | 5,639 | $121.0K |